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ABSTRACT
The biomembrane is postulated as the initial target when Platinum(II) complexes
attack cells. In this work, a spin-labeling ESR technique has been used to study the effects
of cis-DCDP, cis-DBDP, cis-DIDP, trans-DCDP, and cis-DADP on the permeability of
human erythrocyte membrane. We monitored the reduction processes of the ESR signal of
a nitroxide spin label, (TEMPO), which leaks out through the membrane and is reduced by
the external ascorbate. Our results indicate that cisplatin and its analogues can enhance the
permeability of membranes to small moieties such as TEMPO and ascorbate, and the
differences between these compounds are related to features of the leaving group. In
addition, changes in the order parameter of 5DS spin label in membrane indicate that
hydrolysis of these Pt(II) complexes result in membrane damage.
INTRODUCTION
Cisplatin is a broadly used anticancer agent (1). However, its usage has been limited
by kidney toxicity and nephrotoxicity. In the past several years, numerous studies were
focused on the mechanism of the interaction between cisplatin and cells, with particular
attention to the interaction with DNA (1, 2). Recently, the research has been extended to
membrane lipid, membranae protein (3) and cytoskeleton (4). It is believed that the drug-
membrane interaction plays a key role in the toxicity of antitumor agents. A "multi-targets"
mode has been suggested to describe the cellular response as a whole with the biomembrane
as the initial target (3). Any exogenous compounds, including drug molecules must
penetrate the membrane before arriving at other intracellular targets. The interaction of
drug molecules with membrane lipid and membrane protein will influence membrane
permeability. This process is thought to be the basis of toxicity and activity of drugs. In
addition to cis-DCDP, several other analog compounds such as carboplatin (CBDCA) have
been used clinically (5).
In the present work, the effects of cis-DCDP and its analogues on membrane
penetration are reported. Electron spin resonance spectroscopy (6) has been used to
investigate the reaction kinetics between ascorbate and the paramagnetic group of a spin
label intercalated in membrane. The effects of various Pt(II) complexes, such as
cisdichlorodiammineplatinum (cis-DCDP) (I), cisdibromodiammineplatinum (cis-DBDP)
(II), cisdiiododiammineplatinum (cis-DIDP) (III), transdichlorodiammineplatinum (trans-
DCDP) (IV) and cisdiamminediaquoplatinum (cis-DADP)(V) on human erythrocyte
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membrane permeability for the ascorbate ion or the non-ionic spin label TEMPO molecule
have been investigated comparatively.
An additional experiment was conducted to study the influence of Pt(II) complexes
on lipid organization in human erythrocyte membrane. This was done by measuring theand
order parameter of the stearic acid spin label, which is located on the headgroup of the
bilayer.
MATERIALS AND METHODS
Pt(II) complexes were obtained from the Institute of Pharmacy, Beijing Medical
University. The n-doxyl stearic acid spin labels containing 14N nitroxide moieties at the 5,
7, 12 and 16 positions (5DS, 7DS, 12DS and 16DS respectively) and the spin label 2,2,6,6-
tetramethylpiperidine-l-oxyl (TEMPO) were purchased from Sigma Chemical Co. (St.
Louis, MO). Ascorbic acid was from Beijing Phamacia (Beijing). All chemicals were
analytical grade.
Sample preparation and ESR measurement. Fresh human blood was obtained from the
Beijing Red Cross Blood Supply Station. The biomembrane was prepared according to the
Dodge method (7). 100 ml of red cells (2 x 108/ml) was broken in 4000 ml of PBS buffer
(pH = 8.0, 5.0 mmol/L) at4C for 2 hours and then centrifugally washed three times with
PBS buffer at 15,000 rpm, and at 4*C for 10 min. A PBS buffer (pH 7.4, 50 mmol/L) was
used for the final centrifugation step. The white deposit was collected as the erythrocyte
membrane and stored at -20C for use. The membrane protein concentration is 2.5 mg/ml.
A modified Sanberg method (8) was used to prepare samples. The mole
concentration ratio of membrane to spin label is 100" 1. The mixture of membrane and spin
label was incubated at4C overnight. Before ESR measurement, the samples were washed
centrifugally until there was no free spin label in the supernatant. Saline solutions of
various Pt(II) complexes were added to the spin-labeled membranes to a final concentration
of 1.5 mM. The control samples, with saline solution only, were incubated 15 min at 25C,
pH 7.2. Conventional ESR experiments were performed on a Bruker ESP-300 X-band
ESR spectrometer equipped with ER-4111 variable temperature accessory. Spectra were
obtained with 2 mW incident microwave power and 100 KHz field modulation of 2G.
Kinetics of spin label reduction study. Before ESR measurement, at 0C, a freshly
prepared ascorbate solution was added with ten-fold excess molar concentration into the
samples. Time accounting began immediately after mixing. The sample was packed in a
capillary and mounted into the resonance cavity. The ESR spectrum was recorded every
2 minutes while automatically stepping the central magnetic field by 1 Gauss after each
record. The paramagnetic nitroxide group of spin label was reduced by ascorbate, which
resulted in the reduction of the ESR signal amplitude (Fig 1).
The reduction rate of the spin label was quantified by comparing the signal
amplitude on the low-field region of the ESR spectrum, which decreases as the measurement
time increases. The half-time T, when the amplitude of ESR signal reduced to 50% of the
original value, gives the rate of the solutes across the membrane, and the Tou and Tin
represent the permeability of TEMPO molecule and ascorbate ion across the membrane
bilayer, respectively. Also, Tin was used for the stearic acid spin label studies.
The permeation rate of ascorbate into the membrane is temperature dependent (6).
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Samples with TEMPO spin label were measured at 0C, since at this temperature, ascorbate
ion can not penetrate into biomembrane. However, with the stearic acid spin-labeled
system, the experiments were carried out at room temperature at which the ascorbate ion
can enter the membrane bilayer.
The effects of Pt(II) complexes on lipid organization of membrane were studied by
measuring the order parameter of spin label 5DS. The order parameter S which indicates
the fluidity of biomembrane, was calculated following ref.(9).
RESULTS
1. The effects of Pt(II) complexes on the permeability ofTEMPO spin labels from the lipid
bilayer to the outside of the membranes.
Three-dimensional ESR spectra of TEMPO spin label in the human erythrocyte
membrane at different times are shown in Fig. 1. The ESR signal amplitude is reduced by
adding ascorbate ion at 0C.
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Fig. 1. Three-dimensional ESR spectra
of TEMPO spin label in the human
erythrocyte membrane reduced by
adding ascorbate at OC. The time
interval was 2 minutes and the step
change of the center magnetic field was
1G automatically (X-band, 2mW
incident microwave power and 100
KHz field modulation of 2G).
Fig. 2. Time dependence of the normalized
decay curves of the signal amplitude (Ht/Ho)
of TEMPO spin label in the human
erythrocyte membrane reduced by
ascorbate atOC in the presence of various
Pt(II) complexes. Ho is the amplitude of
ESR signal recorded at 2 minutes after the
mixing samples.
The half-time Tou was derived from the normalized decay curve (Fig. 2) and is given
in Table 1. The value of the Tou affected by various Pt(II) complexes is" Tout(0) > Tout(I)
> Tout(II) > Tout(III) > Tout(IV) > Tout(V), and (Tout)max/(Tout)min 1.28.
2. At room temperature, ascorbate ion can penetrate into membrane. The permeation of
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ascorbate from extra-membrane medium into lipid bilayer was affected by various Pt(II)
complexes. Figure 3 is the ESR spectrum of 5DS spin label in human erythrocyte
membrane at different times, and shows that the amplitude of ESR signal was reduced by
adding ascorbate. Half-time Tin was derived from normalized decay curve (Fig. 4) and is
given in Table 1. Tin was affected by various Pt(II) complexes: Tin(0) > Tin (I) > Tin (II)
> Tin(III) > Tin (IV) > Tin(V), but (Tin)max/(Tin)min = 1.81. It was noted that at double the
concentration of cis-DADP, the half-time Tin(V), increased dramatically up to 18.83 min.
Table 1. Half-time Tou for spin label TEMPO leaking out through membrane and being
reduced by ascorbate at 0C, and half-time Tn for ascorbate anion entering the membrane
bilayer and interact with spin label 5DS in the lipid bilayer in the presence of Pt(II)
complexes with a final concentration of 1.5 mM (n=5, and the standard deviation is + 0.3).
Control
(0)
Tou 13.1
Tin 15.95
cis-DCDP
(I)
12.2
14.1
cis-DBDP
(II)
11.6
12.7
cis-DIDP
(III)
11.2
12.1
trans-DCDP
(IV)
10.7
10.3
cis-DADP
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Fig. 3. Three-dimensional ESR
spectra of 5DS spin label in the
human erythrocyte membrane as a
function of the time after adding
ascorbate. The time interval was 2
minutes and the step change of center
magnetic field was 1 Gauss
automatically. Where 2A’ and 2A+/-’
are the parallel and perpendicular
A c,,-octo parts of the hyperfine splitting in the
0 e’" spectra.
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Fig. 4. Time dependence of the
normalized decay curves of the signal
amplitude (Ht/Ho) of 5DS spin label in
human erythrocyte membrane reduced
by ascorbate at room temperature in the
presence of various Pt(II) complexes.
Ho is the amplitude recorded at 2
minutes after the mixing samples.
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Table 2. Half time Tin (min) of spin labels (nDS) at differem depth of lipid bilayer of
human erythrocyte membrane being reduced by ascorbic acid in the presence of Pt(II)
complex with a final concentration of 1.5 mM (n=3).
5DS
7DS
12DS
16DS
control (0)
14.08 0.70
28,.31 1.27
66.81 + 3.34
34.20 __+ 1.39
cis-DCDP (I)
13.28 0.54
25.20 1.13
60.02 2.41
25.29 + 1.28
trans-DCDP(IV)
12.10 0.45
24.86 + 1.02
77.10 __+ 3.44
49.49 + 2.02
cis-DADP(V)
9.79 0.44
22.33 __+ 0.98
55.08 2.31
24.81 +__ 1.28
3. The half-time Tin for various stearic acid spin labels in human erythrocyte membrane was
affected by Pt(II) complexes. For spin labels 5DS, 7DS, 12DS and 16DS, the nitroxide
moieties are located at different depths of the acyl chain of lipid bilayer. The ESR signal
reduction is related to the permeation of ascorbate ion in the membrane. The permeability
of ascorbate ion into the lipid bilayer is influenced by various Pt(II) complexes, and the data
are listed in Table 2. The nitroxide group of the spin label is located near the hydrophilic
region for 5DS and close to the hydrophobic region for 16DS in the membrane. Under the
influence of Pt(II) complexes, the times at which ascorbate ion enters the membrane are"
Ti(5DS) < Tin(7DS) <Tin(16DS) < Tin(12DS). The corresponding permeability of
ascorbate ion with Pt(II) complexes were all higher than the controls.
4. The effects of various Pt(II) complexes on the membrane fluidity. Order parameter S
of stearic acid spin label in the membrane is used to characterize the membrane fluidity.
The S values of 5DS influenced by different Pt(II) complexes in human erythrocyte
membrane are listed in Table 3.
Table 3. The order parameter S of 5DS spin label in the human erythrocyte in the presence
of various Pt(II) complexes with a final concentration of 1.5 mM after incubation 1 hour.
control
(o)
0.746
+0.016
cis-DCDP
(I)
0.775
+ 0.014
cis-DBDP cis-DIDP
(II) (III)
0.778
+ 0.018
0.787
0.020
trans-DCDP
(IV)
0.787
+__ 0.030
cis-DADP
0.791
0.035
DISCUSSION
The method of spin labeling electron paramagnetic resonance was shown to be
applicable to the study of the membrane permeability affected by exogenous compounds.
It provides a unique tool to observe the permeation process of solutes across membranes or
within membrane bilayer at the molecular level (10). The drug effects on the membrane are
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probable due to their influences on the surface structures of biomembranes and the
interactions of Pt(II) complexes with membrane lipid and membrane protein. There is a
consequent change in the membrane fluidity and the conformations of relevant molecules.
A transport process of solute from extracellular space includes at least two
fundamental steps" first is the entry from the extracellular aqueous phase into the lipid
medium (across membrane surface), and the second step is the diffusion along the acyl
chains of phospholipid molecules (diffusion process). A small molecule, such as the spin
label TEMPO, is likely to penetrate through the membrane according to a simple passive
diffusion following a concentration gradient. However, the transport of ascorbate ions is
perhaps due to a facilitated diffusion which has been mediated by a special ion pathway in
the membrane.
The experimental results show that the permeability ofhuman erythrocyte membrane
increases in the presence of Pt(II) complexes for both TEMPO molecule and ascorbate ion.
When Pt(II) complex attack membranes the electrostatic interactions could take place at the
membrane surface, and the positively charged hydrolytic products of these Pt(II) complexes
tend to alter the charge barrier of the membrane surface. Since the hydrolysis of Pt(II)
complex is a slow and reversible process, the system is in a non-equilibrium during the
experiment. Both hydrolytic and non-hydrolytic Pt(II) complexes exist outside the
membrane and change the surface feature of the biomembrane in different manners, which
then affect the permeability of differem solutes (11).
The substitution ability of a ligand (or a leaving group) of a Pt(II) complex in an
aqueous system was summarized (12) in the following order: HzO >C1- > Br- > I-.
However, the hydrolysis of dichlorodiammineplatinum(II) was limited by the relatively high
concentration of chloride ions in the saline solution. Eventually, the two positive charges
of Cisdiaqueodiammineplatinum(II) will influence the surface potential and alter the
negatively-charged barrier of the membrane at some concentration that will facilitate solute
transportation. We noted that the permeation rate of solutes was reduced or Tin was
increased when the cis-DADP concentration was doubled. Perhaps, this is induced by an
increasing of the net positive charges in the polar region of the bilayer. The influence of
hydrolysis is an important factor for ion transport. The changes in the permeation half-time
Tin for ascorbate is more sensitive than Tou for TEMPO molecule in the presence of 1.5 mM
Pt(II) complex. The former changed about 45% and the latter was 22% in this experiment;
although, the change trends of Tin and Tou were similar. On the other hand, Pt(II) non-
hydrolytic complexes are neutral, and their entrance into the lipid bilayer most dependent
on the lipid/water partition coefficient. It has been found that the penetration rates of Pt(II)
into the membrane are in turn increased for cis-DCDP, cis-DBDP and cis-DIDP in response
to their lipid/water portioning (13).
Biomolecules, such as membrane lipids and membrane proteins, possess various
motions and conformations, both influencing the transport of any external substance. The
interactions between Pt(II) complexes, membrane lipids, and proteins will change the
fluidity and the conformation of the membrane and damage the cell membrane at the same
time. The two ammonia molecules of cis-DCDP interact with the phosphate groups of the
polar heads of phospholipids and decrease the mobility of the polar heads in the liposome
(14). Platinum can bind with a high affinity to sulfur-containing molecules, such as
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cysteine, methionine, glutathione, metallothionein and other proteins (2). The binding rate
will be faster after hydrolysis of the Pt(II) complex. The results showed that the order
parameters of membrane lipid at the polar head group were increased by 1.4, 1.8, 2.1, 3
and 3.5% in the presence of cis-DCDP, cis-DBDP, cis-DIDP, trans-DCDP and cis-DADP,
respectively, as compared with the control. With the increasing of the order in the assembly
of bilayer acyl chains, or order parameter, solutes diffuse more easily into the bilayer.
Studies of the permeability at different depths of the membranae bilayer using different spin
labels give a clear picture within the bilayer. They show Pt(II) complexes not only affect
the membrane surface, but also interact with various membrane molecules enhancing solutes
to transport through the membrane bilayer. In general, the longer the diffusion distance,
the larger the half-time of the permeation. The data shows that Tin (16DS) < Tin (12DS)
is very interesting. It is possible that the vertical fluctuation of the phospholipid is
responsible for the results (15).
Transdichlorodiammine-platinum possesses a six times higher lipid/water partition
coefficient than cisdichlorodiammine-platinum, easy hydrolysis, and strong interaction with
membrane molecules; all of which promote solutes across membrane. It has been observed
that the trans-Pt reacts more rapidly with GSH compared with cis-Pt(2). The lipid-solubility
for cis-DIDP, cis-DBDP and cis-DCDP are lower in turn and are all smaller than trans-
DCDP’s.
In conclusion, cisplatin and its analogues interact with membranes and affect the
biophysical property of the lipid bilayer. This work reveals that the effects of various
platinum complexes with different ligands on the permeability of membrane are related to
their hydrolyzing, partitioning, and interacting with membrane molecules. These effects are
certainly important for the transportation of other ions, such as Na+, K+, C1- and Ca+ + ions
which maintain the normal physiological functions of cells and may contribute to the toxicity
mechanism of Pt(II).
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